Alto Neuroscience (ANRO) Treasury Shares (2023 - 2025)
Alto Neuroscience (ANRO) posted Treasury Shares of $27000.0 for Q4 2025, little changed sequentially from $27000.0 in Q3 2025, and down 50.0% YoY from $54000.0 in Q4 2024.
Alto Neuroscience (ANRO) Treasury Shares (2023 - 2025) Analysis & Trends
Alto Neuroscience has reported Treasury Shares for 3 years, with the latest figure at $27000.0 in Q4 2025.
- Quarterly Treasury Shares fell 50.0% year-over-year to $27000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27000.0 (down 50.0% YoY) and the FY2025 annual result came in at $27000.0, down 50.0% from the prior year.
- Treasury Shares was little changed at $27000.0 in Q4 2025 per ANRO's latest filing, from $27000.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $29.9 million in Q4 2023 and troughed at $27000.0 in Q3 2025.
- A 3-year average of $13.0 million and a median of $20.4 million in 2023 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares plunged 99.82% in 2024, then plunged 50.0% in 2025.
- Over 3 years, Treasury Shares stood at $29.9 million in 2023, then slumped by 99.82% to $54000.0 in 2024, then slumped by 50.0% to $27000.0 in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $27000.0, $27000.0, and $54000.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Alto Neuroscience | 1.13 Bn | 1.13 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27,000.00 |
| Dec 31, 2025 | 27,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Dec 31, 2023 | 29.92 Mn |
| Dec 31, 2023 | 29.92 Mn |
| Sep 30, 2023 | 20.37 Mn |
| Sep 30, 2023 | 20.37 Mn |
| Jun 30, 2023 | 20.37 Mn |
| Jun 30, 2023 | 20.37 Mn |
| Mar 31, 2023 | 20.37 Mn |
| Mar 31, 2023 | 20.37 Mn |